首页
>>
产品中心
>>
蛋白产品
>>
重组蛋白
>
Mouse HAVCR2 Protein, His Tag

Mouse HAVCR2 Protein, His Tag

产品编号

KMP2340

别名

甲型肝炎病毒细胞受体 2, Hepatitis A virus cellular receptor 2, HAVCR2

规格
  • 50ug
  • 100ug
  • 200ug
产品介绍
Catalog NumberKMP2340
Alias甲型肝炎病毒细胞受体 2, Hepatitis A virus cellular receptor 2, HAVCR2
Size50ug, 100ug, 200ug
Product DescriptionThe Mouse HAVCR2 Protein(KMP2340) is produced in HEK293 Cells and the target gene encoding Arg20-Ala193 is expressed with a 6His tag at the C-terminus.
Molecular NameHAVCR2
Product IntroductionHAVCR2(TIM-3):免疫调节跨膜蛋白,在耗竭T细胞表面高表达,参与免疫应答的负调控。
Molecular Weight19.95 kDa
Expression SystemHEK293 Cells
SpeciesMouse
Purity>95%
PurificationAffinity Purification
Uniprot IDQ3KP82
Storage ConditionAliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.4
Shipping ConditionIn general, the proteins are provided as lyophilized powder which are shipped at ambient temperature. They are shipped out in dry ice if supplied in liquid form.
BackgroundT cell immunoglobulin and mucin domain-3(TIM3), also called hepatitis A virus cellular receptor 2(HAVCR2), is a transmembrane glycoprotein of the TIM family of immune regulating molecules and plays an important role in the Th1-mediated immune response. TIM3 is expressed on the Th1 cells, CD8 T-cells, monocytes, and dendritic cells, but not on Th2 cells. TIM3 expressed by monocytes and dendritic cells facilitates phagocytosis of apoptotic cells and up-regulates cross-presentation of apoptotic cell-associated antigens through interaction with phosphatidylserine. Engagement of TIM3 by its ligand galectin-9 induces a range of immunosuppressive functions which enhance immune tolerance and inhibit anti-tumor immunity. Stimulation of TIM3 with an agonistic antibody promotes inflammation through the activation of innate immune cells. TIM3 is also regarded as a potential target molecule for immunotherapy. TIM3 and programmed cell death 1(PD-1) as two important coinhibitory regulators of T cell responses, have been implicated with the T-cell dysfunction or exhaustion associated with chronic HBV infection including HBV-related HCC.
Endotoxin<1.0 EU/ug determined by the LAL method
Product Declaration该产品仅供科研使用,不可直接用于人体或注射。
FAQ
  • 蛋白溶解后浓度偏低,如何调整?:低速离心:12,000 rpm, 5分钟,去除不溶物。缓冲液置换:使用超滤离心管(如10 kDa截留分子量)浓缩。

  • 如何提高重组蛋白的可溶性表达?:可优化表达条件(如降低诱导温度、调整IPTG浓度)、使用促溶标签(如SUMO、GST)、共表达分子伴侣,或尝试不同宿主系统(如哺乳动物细胞或昆虫细胞)以提高可溶性蛋白产量。

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价